A subset of cancer cells under replication stress may be susceptible to ATR inhibitors, as well as other DDR inhibitors, such as CHK1 [168, 169] or WEE1 [177, 180] under MYC- or CCNE1-induced replication stress. Here, MYC is linked to cancer.